Edition:
United Kingdom

Rigel Pharmaceuticals Inc (RIGL.OQ)

RIGL.OQ on NASDAQ Stock Exchange Global Select Market

3.56USD
15 Dec 2017
Change (% chg)

$-0.01 (-0.28%)
Prev Close
$3.57
Open
$3.66
Day's High
$3.68
Day's Low
$3.42
Volume
4,968,851
Avg. Vol
460,970
52-wk High
$4.47
52-wk Low
$1.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.156
Mar '17 3.58 -0.135
FY 2016 Dec '16 3.00 -0.157
Sep '16 3.76 -0.237
Jun '16 8.59 -0.146
Mar '16 5.03 -0.193
FY 2015 Dec '15 8.54 -0.142
Sep '15 13.00 -0.075
Jun '15 5.18 -0.158
Mar '15 2.18 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.01 0.05 0.00 6.00
Quarter Ending Mar-18 1 0.00 0.00 0.00 11.00
Year Ending Dec-17 5 4.39 4.50 4.00 10.73
Year Ending Dec-18 5 15.93 35.00 2.71 37.16
Earnings (per share)
Quarter Ending Dec-17 5 -0.13 -0.12 -0.14 -0.17
Quarter Ending Mar-18 2 -0.14 -0.13 -0.15 -0.16
Year Ending Dec-17 5 -0.56 -0.56 -0.57 -0.65
Year Ending Dec-18 5 -0.52 -0.40 -0.65 -0.47
LT Growth Rate (%) 1 61.00 61.00 61.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 1.16 0.85 0.88
Price to Sales (TTM) 46.66 100.68 5.40
Price to Book (MRQ) 6.93 13.50 5.38
Price to Tangible Book (MRQ) 6.93 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 90.02 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -70.58 75.04 5.38
Sales - 5 Yr. Growth Rate 33.82 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -6.83 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -23.09 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -18.98 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 5.28 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -659.36 -- --
EBITD - 5 Yr. Avg -561.14 -261.13 15.24
Operating Margin (TTM) -716.09 -556.69 7.76
Operating Margin - 5 Yr. Avg. -600.02 -279.31 10.75
Pre-Tax Margin (TTM) -702.63 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -596.84 -279.05 11.17
Net Profit Margin (TTM) -702.63 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -596.84 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 134,338 25,316,769 864,680,848
Net Income/Employee (TTM) -943,896 3,332,346 101,718,394
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.11 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.66 -0.77 11.00
Return on Assets - 5 Yr. Avg. -40.37 -0.26 12.43
Return on Investment (TTM) -98.94 2.36 14.46
Return on Investment - 5 Yr. Avg. -44.27 2.98 16.28
Return on Equity (TTM) -101.42 2.96 16.05
Return on Equity - 5 Yr. Avg. -46.31 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -29.46 41.79 33.82
EPS (TTM) % -26.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rigel Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 53.36 48.07 95 53
13 Week 45.86 38.76 90 60
26 Week 25.57 16.02 78 69
52 Week -1.02 -16.11 49 46
YTD 63.03 43.17 81 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.27%
# of Holders: 151
Total Shares Held: 111,724,727
3 Mo. Net Change: -263,101
# New Positions: 13
# Closed Positions: 17
# Increased Positions: 55
# Reduced Positions: 59
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.